Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1225-1231

  Ghabeljoo, Manijeh ^a   Jafarabadi, Mohammad Asghari ^b   Mohammadi, Seyede Momeneh ^c   Hajizadeh, Ebrahim ^d   Kazemnejad, Anoshirvan ^e   Fatemi, Seyed Reza ^e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Faculty of Health and Nutrition   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Grade; Iran; Stage; Survival patterns

Indexed keywords

EID: 84857969981     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Adams K, Leitzmann M, Albanes D et al. (2007) Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiology, 166, 36-45.
2. American joint committee on cancer (1988) AJCC Cancer Staging Manual (ed 3). Available at:http://www.cancerstaging.org/products/ajccproducts.html.
3. American Cancer Society (2008) Cancer Facts and Figures 1999-2008
4. Ansari R, Mahdavinia M, Sadjadi A, et al (2006). Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett 18, 240, 143-7.
5. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad, et al (2009). Site-Specific Evaluation of Prognostic Factors in Iranian Colorectal Cancer Patients: A Competing Risks Survival Analysis. Asian Pacific Journal of Cancer Prevention, 10, 815-822.
6. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad, et al (2010a). A comparative study on the prognostic impact of concurrent smoking and alcohol drinking on colon and rectal cancers: A frailty competing risks survival analysis. Gastroenterology and Hepatology From Bed to Bench, 3, 19-26.
7. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, et al (2010b). Overcoming the Problem of Independence Assumption in Competing Risks Model by Gamma Frailty Models: Application for Iranian Colorectal Cancer Patients. JP Journal of Biostatistics, 4, 123-138.
8. Azadeh S, Moghimi-Dehkordi B, Fatem SR, et al (2008). Colorectal cancer in iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
9. Berrino F, De-Angelis R, Rosso MSS, et al (2007). Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol, 8, 773-783.
10. Boyle P, Langman JS (2000). ABC of colorectal cancer. bmj, 321, 805-808.
11. Capocaccia R, Angelis RD, Frova L, et al (1997). Estimation and Projections of Colorectal Cancer Trends in Italy. International Journal of Epidemiology, 26, 924-932.
12. Cheng X, Chen VW, Steele B, et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer, 92, 2547-54.
13. Chyke A Doubeni, Terry S Field, Diana SM Buist, et al (2007). Racial Differences in Tumor Stage and Survival for Colorectal Cancer in an Insured Population. Cancer, 109, 612-20.
14. Chyou PH, Nomura AMY, Stemmermann GN (1996). A prospective study of colon and rectal cancer among Hawaii Japanese men. Annals of Epidemiology, 6, 276-282.
15. Ciccolallo L, Capocaccia R, Coleman MP, et al (2005). Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut, 54, 268-273.
16. Colditz, GA, Cannuscio CC, Frazier AL (1997). Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control, 8, 649-67.
17. Du W, Mah JTL, Lee J, Sankila R (2004). Incidence and survival of mucinous adenocarcinoma of the colorectum: a population- based study from an Asian country. Dis Colon Rectum, 47, 78-85.
18. Fatemi R, Mohammad Alizadeh AH, Derakhshan F, et al (2009). Colorectal Stenting for Management of Acute Malignant Bowel Obstruction in Advanced Colorectal Cancer in Iran. Asian Pacific J Cancer Prev, 10, 739-741.
19. Fatemi, SR, Malek FN, Shivarani S, et al (2010). Prevalence of Colorectal Cancer in Relatives of Iranian Patients Diagnosed with Colorectal Cancer. Asian Pacific J Cancer Prev, 10, 91-93.
20. Finkelstein M, Esaulova V. (2008) On asymptotic failure rates in bivariate frailty competing risks models. Statistics and Probability Letters, 78, 1174-1180.
21. Foroutan M, Rahimi N, Tabatabaeifar M, et al (2008). Clinical features of colorectal cancer in Iran: A 15-year review. Journal of Digestive Diseases, 9, 225-227.
22. Gatta G, Ciccolallo L, Capocaccia R, et al (2003). Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer, 39, 2214-22.
23. Gatta G, Faivre J, Capocaccia R, et al (1998). Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur. J. Cancer Prev, 34, 2176-83.
24. Gerhardsson-Deverdier M, Hagman U, Steineck G, et al (1990). Diet, body mass and colorectal cancer: a case-referent study in Stockholm. IntJ Cancer, 46, 332-338.
25. Haidinger G, Waldhoer T, Hackl M, et al (2006). Survival of patients with colorectal cancer in Austria by sex, age, and stage. Wien Med Wochenschr, 156, 549-551.
26. Hall NR, Finan PJ, Brown S, et al (2000). Comparison of prognosis in cancer of the colon and rectum. Colorectal Disease, 2, 159-164.
27. Halvorsen TB, Seimt E (1988). Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J Clin Pathol, 41, 532-537.
28. Hayne D, Brown RSD, Mccormack M, et al (2001). Current Trends in Colorectal Cancer: Site, Incidence, Mortality and Survival in England and Wales. Clinical Oncology, 13, 448-452.
29. Hodadoostan MK, Fatemi R, Maserat E, et al (2010) Clinical & Pathology Characteristics of Colorectal Polyps in Iranian Population. Asian Pacific J Cancer Prev, 11, 557-560.
30. Hosseini S, Izadpanah A & Yarmohammadi H. (2004) Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg, 74, 547-549.
31. Hotokezaka M, Jimi SI, Hidaka H, et al (2008) Factors Infl uencing Outcome After Surgery for Stage IV Colorectal Cancer. Surg Today, 38, 784-789.
32. Klein JP, Bajorunaite R (2004). Inference for competing risks. In Advances in survival analysis, Handbook of statistics (Vol. 23, pp. 291-311), Amsterdam, Elsevier.
33. Kleinbaum DG, Klein M (2005). Survival Analysis: A Self-Learning Text, New York, Springer.
34. Kobayashi H, Ueno H, Hashiguchi Y, et al (2006). Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery, 139, 516-522.
35. Li FY, Lai MD (2009). Colorectal cancer, one entity or three? Journal of Zhejiang University SCIENCE B, 10, 219-229.
36. Li M, Li JY, Zhao AL, et al (2007). Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology, 73, 52-57.
37. Lunn M, Mcneil D. (1995) Applying Cox regression to competing risks. Biometrics, 51, 524-532.
38. Meguid RA, Slidell MB, Wolfgang CL, et al (2008). Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers? Annals of Surgical Oncology, 15, 2388-2394.
39. Moghimi-Dehkordi B, Safaee A, Zali MR (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis, 4, 683-688.
40. National Cancer Institute (2007). SEER Cancer Statistics Review 1975-2003. US Department of Health and Human Services, Available at: http://seer.cancer.gov/statfacts/html/colorect.html.
41. Pahlavan PS, Jensen K (2005). A short impact of epidemiological features of colorectal cancer in Iran. Tumori, 91, 291-4.
42. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-932.
43. Radzniwan M, Rashid A, Aziz AFA, et al (2009). Colorectal Cancer Patients in a Tertiary Referral Centre in Malaysia: a Five Year Follow-up Review. Asian Pacific J Cancer Prev, 10, 1163-1166.
44. Roncucci L, Fante R, Losi L, et al (1996). Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer Prev, 32, 295-302.
45. Slattery ML, Edwards S, Curtin K, et al (2003). Physical Activity and Colorectal Cancer. Am J Epidemiol, 158, 214-224.
46. Sriamporn S, Wiangnon S, Suwanrungruang K, et al (2007). Risk Factors for Colorectal Cancer in Northeast Thailand: Lifestyle Related. Asian Pacific J Cancer Prev, 8, 573-577.
47. Steinberg SM, Barkin JS, Kaplan RS, et al (1986). Prognostic Indicators of Colon Tumors. Cancer, 57, 1866-1870.
48. Takahashi K, Mori T, Yasuno M (2000). Histologic grade of metastatic lymph node and prognosis of rectal cancer. Dis Colon Rectum, 43, S40-S46.
49. Wei E K, Giovannucci E, Wu K, et al (2004) Comparison of risk factors for colon and rectal cancer. Int J Cancer, 108, 433-442.
50. Wilkes G, Hartshorn K (2009). Colon, Rectal, and Anal Cancers. Seminars in Oncology Nursing, 25, 32-47.
51. Winawer SJ, Zauber AG, Ho MN, et al (1993). Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med, 329, 1977-1981.
52. World Health Organization. (2000) International classification of diseases for oncology, Geneva.
53. Xu FY, Zhai MJ, Dong JK, et al (2006). Clinical pathological factors function differently in colonic and rectal cancer prognosis. Journal of Zhejiang University(Medical Science), 3, 303-310.
54. Yu XQ, O'Connell DL, Gibberd RW, et al (2008). Misclassification of colorectal cancer stage and area variation in survival. Int. J. Cancer, 122, 398-402.
55. Zampinoa MG, Labianca R, Beretta G, et al (2004). Rectal cancer. Critical Reviews in Oncology/Hematology, 51 121-143.